Orphazyme A/S Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
0.00
-26.00
-41.00
-83.00
-635.00
-342.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-3.00
0.00
-3.00
0.00
42.00
2.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-3.00
-20.00
-104.00
-602.00
-539.00
-326.00
Cash Flow from Investing Activities
-9.00
-6.00
90.00
0.00
-5.00
-3.00
Cash Flow from Financing Activities
5.00
0.00
-35.00
-30.00
1,159.00
58.00
Net Cash Inflow / Outflow
-7.00
-27.00
-48.00
-624.00
603.00
-271.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
8.00
-11.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in DKK Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Orphazyme A/S
Figures in Million
consolidated Cash Flow Results
Change(DKK)
Change(%)
Profit Before Tax
-0.298
971.357
-971.00
-100.03%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-3.422
176.914
-179.00
-101.93%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-3.361
1949.832
-1,952.00
-100.17%
Cash Flow from Investing Activities
-9.327
-1870.863
1,861.00
99.50%
Cash Flow from Financing Activities
5.306
55.775
-50.00
-90.49%
Net Cash Inflow / Outflow
-7.383
146.256
-153.00
-105.05%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.001
11.512
-11.00
-100.01%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 83.21% vs 80.84% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-3.36
-20.02
83.21%






